-
Changing the Face of Clinical Trials
Efforts are under way to increase African-American enrollment in cancer clinical trials.
by Leslie Harris O'Hanlon
-
Forever Young
In images of four breast cancer survivors navigating the medical system, photographer David Jay captures portraits of emotional strength, economic struggle and hope.
by Cynthia Ryan
-
In the Moment- Spring 2013
Valentina Londono, Beth Foster, Michael Knowlton, Beverly Brehl.
-
Survivor Profile
Macho ManCarlos De La Cuesta is redefining manhood after prostate cancer.
by Jocelyn Selim
-
When Cancer Rings Twice
One out of every six people diagnosed with cancer this year will be facing it for, at least, the second time.
by Melissa Weber
-
Survivor Profile
Let’s Talk: Lee MillerDrawing on her own struggle with the emotional pain of a cancer diagnosis and treatment, Lee Miller empowers other patients to effectively communicate with their doctors.
by Jenny Song
-
Yesterday & Today
The Sex Machine vs. Prostate CancerEven cancer couldn't slow down James Brown.
by Jocelyn Selim
-
Survivor Profile
Patients’ Rights PowerhouseMyra Christopher wages a personal battle with a rare cancer while continuing to passionately advocate for patients.
by Charlotte Huff
-
In the Moment- Winter 2012/2013
Julia Wiley, Tony Handler, Michael B. Lawing, Lori Petitti
-
First Person
Keeping Sight of HopeA survivor keeps an eye on what's ahead after a rare cancer diagnosis.
by Sue Russell
Cancer Talk
Screening Options for People With Dense Breasts
Reports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore
Designing Clinical Trials for the PatientChallenges in developing and studying treatments call for new ways of thinking about cancer research.
by Eric Fitzsimmons
Treating Smoldering Multiple MyelomaA monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon